Aethlon Medical (NASDAQ:AEMD) Share Price Passes Above 200-Day Moving Average – Time to Sell?

Aethlon Medical, Inc. (NASDAQ:AEMD) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.42 and traded as high as $0.60. Aethlon Medical shares last traded at $0.57, with a volume of 1,309,468 shares traded.

Analyst Ratings Changes

Several equities analysts have issued reports on AEMD shares. StockNews.com started coverage on Aethlon Medical in a research note on Thursday. They issued a “sell” rating on the stock. HC Wainwright restated a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Trading Up 3.2 %

The company has a 50-day moving average of $0.41 and a 200-day moving average of $0.43. The company has a market capitalization of $8.20 million, a price-to-earnings ratio of -0.21 and a beta of 1.79.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.